NasdaqGS - Nasdaq Real Time Price USD
Dynavax Technologies Corporation (DVAX)
9.69
-0.03
(-0.31%)
At close: May 8 at 4:00:01 PM EDT
10.10
+0.41
+(4.23%)
Pre-Market: 8:09:55 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BURGESS JUSTIN Officer | Conversion of Exercise of derivative security | Feb 10, 2025 | 4,170 |
| CANO FRANCIS R. PH.D. Director | Sale | May 31, 2024 | 36,905 |
| JANSSEN ROBERT Officer | Conversion of Exercise of derivative security | Feb 18, 2025 | 77,485 |
| MACDONALD KELLY Chief Financial Officer | Conversion of Exercise of derivative security | Feb 18, 2025 | 29,227 |
| MACGREGOR BRENT Director | Stock Award(Grant) | May 23, 2024 | 16,071 |
| NOVACK DAVID F President | Sale | Mar 24, 2025 | 8,078 |
| PARADISO PETER R Director | Stock Award(Grant) | May 23, 2024 | 19,071 |
| SLEBIR JOHN L General Counsel | Conversion of Exercise of derivative security | Feb 18, 2025 | 36,373 |
| SPENCER RYAN Chief Executive Officer | Conversion of Exercise of derivative security | Feb 18, 2025 | 260,733 |
| SUN ELAINE D Director | Stock Award(Grant) | May 23, 2024 | 24,107 |
Related Tickers
ESPR Esperion Therapeutics, Inc.
0.8928
+2.51%
BCRX BioCryst Pharmaceuticals, Inc.
9.92
-1.59%
EBS Emergent BioSolutions Inc.
6.36
+34.18%
PCRX Pacira BioSciences, Inc.
24.91
-1.07%
COLL Collegium Pharmaceutical, Inc.
27.27
+0.81%
AKBA Akebia Therapeutics, Inc.
2.6200
+6.50%
SUPN Supernus Pharmaceuticals, Inc.
31.54
+1.94%
NBIX Neurocrine Biosciences, Inc.
117.52
-3.36%
AVDL Avadel Pharmaceuticals plc
9.39
-0.84%
AMPH Amphastar Pharmaceuticals, Inc.
24.65
+0.90%